CLINICAL RESEARCH
An Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction
John J. Mahmarian, MD*,*,
Habib A. Dakik, MD ,
Neil G. Filipchuk, MD ,
Leslee J. Shaw, PhD ,
Sherif S. Iskander, MD||,
Terrence D. Ruddy, MD¶,
Felix Keng, MD#,
Milena J. Henzlova, MD**,
Adel Allam, MD,
Lemuel A. Moyé, MD, PhD,
Craig M. Pratt, MD* for the INSPIRE Investigators
* Methodist DeBakey Heart Center, Department of Cardiology, The Methodist Hospital, Houston, Texas USA
American University of Beirut, Beirut, Lebanon
University of Calgary, Calgary, Alberta, Canada
Cedars-Sinai Medical Center, Los Angeles, California USA
|| Cardiovascular Associates of East Texas, Tyler, Texas USA
¶ University of Ottawa Heart Institute, Ottawa, Ontario, Canada
# National Heart Centre, Singapore, Singapore
** Mount Sinai Medical Center, New York, New York USA
Al-Azhar University, Cairo, Egypt
University of Texas School of Public Health, Houston, Texas USA
Manuscript received March 30, 2006;
revised manuscript received July 5, 2006,
accepted July 6, 2006.
* Reprint requests and correspondence: Dr. John J. Mahmarian, Department of Cardiology, Methodist DeBakey Heart Center, 6550 Fannin Street, SM-677, Houston, Texas 77030. (Email: jmahmarian{at}tmh.tmc.edu).
OBJECTIVES: The purpose of this study was to determine the relative benefit of intensive medical therapy compared with coronary revascularization for suppressing scintigraphic ischemia.
BACKGROUND: Although medical therapies can reduce myocardial ischemia and improve patient survival after acute myocardial infarction, the relative benefit of medical therapy versus coronary revascularization for reducing ischemia is unknown.
METHODS: A prospective randomized trial in 205 stable survivors of acute myocardial infarction was made to define the relative efficacy of an intensive medical therapy strategy versus coronary revascularization for suppressing scintigraphic ischemia as assessed by serial gated adenosine Tc-99m sestamibi myocardial perfusion tomography. All patients at baseline had large total ( 20%) and ischemic (10%) adenosine-induced left ventricular perfusion defects and an ejection fraction 35%. Imaging was performed during 1 to 10 days of hospital admission and repeated in an identical fashion after optimization of therapy. Patients randomized to either strategy had similar baseline demographic and scintigraphic characteristics.
RESULTS: Both intensive medical therapy and coronary revascularization induced significant but comparable reductions in total (–16.2 ± 10% vs. –17.8 ± 12%; p = NS) and ischemic (–15 ± 9% vs. –16.2 ± 9%; p = NS) perfusion defect sizes. Likewise, a similar percentage of patients randomized to medical therapy versus coronary revascularization had suppression of adenosine-induced ischemia (80% vs. 81%; p = NS).
CONCLUSIONS: Sequential adenosine sestamibi myocardial perfusion tomography can effectively monitor changes in scintigraphic ischemia after anti-ischemic medical or coronary revascularization therapy. A strategy of intensive medical therapy is comparable to coronary revascularization for suppressing ischemia in stable patients after acute infarction who have preserved LV function.
|
Abbreviations and Acronyms
| | ADSPECT = adenosine technetium-99m sestamibi single-photon emission computed tomography | | AMI = acute myocardial infarction | | BB = beta-blockers | | CABG = coronary artery bypass grafting | | CAD = coronary artery disease | | CCB = calcium-channel blocker | | EF = ejection fraction | | LAD = left anterior descending | | LV = left ventricular | | PCI = percutaneous coronary intervention | | PDS = perfusion defect size |
|
Related Article
-
Noninvasive Risk Stratification After Myocardial Infarction: New Evidence, New Questions
- Raymond J. Gibbons and Todd D. Miller
J. Am. Coll. Cardiol. 2006 48: 2468-2470.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
G. A. Diamond and S. Kaul
The Disconnect Between Practice Guidelines and Clinical Practice--Stressed Out
JAMA,
October 15, 2008;
300(15):
1817 - 1819.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Katritsis and B. Meier
Percutaneous Coronary Intervention for Stable Coronary Artery Disease
J. Am. Coll. Cardiol.,
September 9, 2008;
52(11):
889 - 893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Schomig, J. Mehilli, A. de Waha, M. Seyfarth, J. Pache, and A. Kastrati
A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease
J. Am. Coll. Cardiol.,
September 9, 2008;
52(11):
894 - 904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Zoghbi, T. A. Dorfman, and A. E. Iskandrian
The Effects of Medications on Myocardial Perfusion
J. Am. Coll. Cardiol.,
August 5, 2008;
52(6):
401 - 416.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Hachamovitch and M. F. Di Carli
Methods and Limitations of Assessing New Noninvasive Tests: Part II: Outcomes-Based Validation and Reliability Assessment of Noninvasive Testing
Circulation,
May 27, 2008;
117(21):
2793 - 2801.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Shaw, D. S. Berman, D. J. Maron, G. B. J. Mancini, S. W. Hayes, P. M. Hartigan, W. S. Weintraub, R. A. O'Rourke, M. Dada, J. A. Spertus, et al.
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Circulation,
March 11, 2008;
117(10):
1283 - 1291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. J. Th. Wackers, D. A. Chyun, L. H. Young, G. V. Heller, A. E. Iskandrian, J. A. Davey, E. J. Barrett, R. Taillefer, S. D. Wittlin, N. Filipchuk, et al.
Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study
Diabetes Care,
November 1, 2007;
30(11):
2892 - 2898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
988 - 1003.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Idelchik, D. H. Steinberg, J. J. Ferguson, and R. Waksman
Assessing Risk After Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
June 5, 2007;
49(22):
2227 - 2227.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mahmarian and C. M. Pratt
Reply
J. Am. Coll. Cardiol.,
June 5, 2007;
49(22):
2227 - 2228.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mahmarian, L. J. Shaw, N. G. Filipchuk, H. A. Dakik, S. S. Iskander, T. D. Ruddy, M. J. Henzlova, F. Keng, A. Allam, L. A. Moye, et al.
A Multinational Study to Establish the Value of Early Adenosine Technetium-99m Sestamibi Myocardial Perfusion Imaging in Identifying a Low-Risk Group for Early Hospital Discharge After Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2448 - 2457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons and T. D. Miller
Noninvasive Risk Stratification After Myocardial Infarction: New Evidence, New Questions
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2468 - 2470.
[Full Text]
[PDF]
|
|
|
|
